A dual dopaminergic therapy with L-3,4-dihydroxyphenylalanine and chlorpromazine for the treatment of blepharospasm, a focal dystonia: Possible implications for striosomal D1 signaling
Article in Frontiers in Neurology (July 2022)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Medical treatment of blepharospasm
Article in Expert Review of Ophthalmology (July 2018)
Cholinesterases and the fine line between poison and remedy
Article in Biochemical Pharmacology (January 2018)